Characteristic | ABPA | Non-atopic asthma | Healthy |
---|---|---|---|
n | 10 | 10 | 10 |
Age (year) (median, IQR) | 59.5 year (55.7–66.1) | 46.0 year (37.4–57.3) | 38.0 year (31.2–51.1) |
% Male | 40.0Â % (4/10) | 20Â % (2/10) | 40Â % (4/10) |
Asthma (%) | 70Â % (7/10) | 100Â % (10/10) | 0 % (0/10) |
Lung function tests (n) | 5 | 9 | N/A |
FEV1 % predicted (median, IQR) | 75.0 (71.0–80.0) | 85.0 (58.0–105.0) | N/A |
FVC % predicted (median, IQR) | 103.0 (102.0–106.0) | 113.0 (89.0–116.0) | N/A |
FEV1/FVC ratio (median, IQR) | 60.8 (55.0–63.4) | 78.0 (46.0–81.0) | N/A |
Markers of ABPA | Â | Â | N/A |
Bronciectasis (%) | 80Â % (8/10) | 50Â % (5/10) | N/A |
Total serum IgE (kU/L) (median, IQR) (n) | 4100 (2650–7075) (10) | 71.9 (63.4–110.0) (10) | N/A |
Aspergillus specific IgE (kUA/L) (median, IQR) (n) | 34.0 (2.9–60.3) (6) | N/A | N/A |